ALAMEDA, Calif., Penumbra, Inc., a global interventional therapies company, today announced the U.S. launch of its new POD ® Packing Coil, designed to be used as a complementary device with Penumbra’s ...

Penumbra has released a new embolization packing coil designed for work on peripheral vessels and aneurysms. The POD Packing Coil is intended for use along with the company’s Ruby and POD embolization ...

Penumbra has announced US Food and Drug Administration approval for its Ruby XL system, which includes three coils: the Ruby XL, the POD XL and the Packing Coil XL. The Ruby XL coil is a device used ...

ALAMEDA, Calif., June 5, 2025 /PRNewswire/ -- Penumbra, Inc (PEN). (NYSE: PEN) announced the U.S. Food and Drug Administration (FDA) clearance and launch of the Ruby ® XL System, the longest, largest ...

ALAMEDA, Calif.--(BUSINESS WIRE)--Today Penumbra, Inc. announced the US launch of the Penumbra Coil 400, a stretch-resistant, platinum embolic coil that has a 400% volume filling advantage compared to ...

April 14, 2011 — A total of 267 lots of the Penumbra Coil 400 are subject to a class 1 recall by the US Food and Drug Administration (FDA). A drug safety alert on the coil was sent yesterday from ...

A software designer is suing a California company, claiming its medical device used to treat aneurysms malfunctioned and caused him to suffer brain damage. The Penumbra Coil 400 was used to treat an ...

SEATTLE — A software designer is suing a California company, claiming its medical device used to treat aneurysms malfunctioned and caused him to suffer brain damage. The Penumbra Coil 400 was used to ...

"We've engineered Ruby XL to deliver more volume per coil than any other coil on the market, which may result in cost savings," said Shruthi Narayan, President of Interventional Business at Penumbra, ...